AKT1 and hepatocellular carcinoma: 6-shogaol combined with 5-fluorouracil (5-FU) triggers apoptosis and cell cycle arrest in hepatocellular carcinoma cells by inhibiting AKT/mTOR/MRP-1 signaling.